Genmab — Marts 2020

[E_L]

yes, i hope it doesn't get delayed with all that is happening right now. But i assume EMA people can easily do all of this from home

[Plimsoller]

God morgen

[Helge_LarsenPI-redaktør]

God morgen.

[E_L]

From Novartis: At this time, we do not anticipate any delays to regulatory submissions.
 Upcoming launches of ofatumumab, capmatinib, inclisiran all filed with respective health authorities.
Pre-launch activities continue as planned.
 Ofatumumab is manufactured in Switzerland https://www.novartis.com/sites/www.novartis.com/files/novartis-frequently-asked-questions-covid-19.pdf

[Sukkeralf]

Nice E L

[Sukkeralf]

The most problematic in my opinion is Genmabs CD20/CD3 - if it gets delayed due to hard times starting new clinical trials. Maybe even more important now to get a partner deal and BP on board. They can spend time planning and stuff while the Corona virus slow things down

[E_L]

yes, not easy to close a deal though when you can't meet anyone i imagine.. ideally you don't do this over the phone... cross fingers...

[E_L]

are we expecting anything from Symphony Health
today?

[bibob]

Yes E L. - Maybe silende.

[bibob]

Silence

[JKY_VH]

Hvis ikke der er "solgt" noget i februar, er der heller noget at rapportere om ud over 0, som nohope sikkert vil svare:-)

[bibob]

[StockBull]

Pæn volumen - mon nogen allerede har set Feb. tallene

[StockBull]

52.000 på første 25 min

[Helge_LarsenPI-redaktør]

Just a moment...

(www.proinvestor.com)

[nohope]

Februar tal er kun marginalt påvirkede af corona, eller slet ikke påvirkede. Det kommer først senere.

[StockBull]

Nemlig. Og JNJ regnskab for Q1 will snart indikere hvordan landet ligger

[Sukkeralf]

Mit gæt er at flere pharmaselskaber vil miste ca 1 måneds indtjening i år

[Sukkeralf]

omsætning - ikke indtjening ! Udgifterne vil formentlig også blive lavere, så i sidste ende vil det formentlig ikke være specielt drastisk

[StockBull]

JNJ https://seekingalpha.com/news/3554647-j-and-j-finance-chief-warns-on-reliability-of-guidance-amid-covidminus-19-outbreak?utm_medium=email&utm_source=seeking_alpha&mail_subject=jnj-j-j-finance-chief-warns-on-reliability-of-guidance-amid-covid-19-outbreak&utm_campaign=rta-stock-news&utm_content=link-1